Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Actuate Therapeutics Inc | 10,049,996 | 10,049,996 | 0 | $27.54M | $15.38M | 36.90% | -$12.16M |
| Opus Genetics, Inc.(IRD) | 3,683,429 | 3,683,429 | 0 | $16.76M | $15.14M | 36.33% | -$1.62M |
| Cognition Therapeutics, Inc.(CGTX) | 6,000,000 | 6,000,000 | 0 | $4.56M | $6.90M | 16.56% | +$2.34M |
| Rein Therapeutics Inc.(RNTX) | 1,982,375 | 2,982,375 | +1,000,000 | $2.58M | $3.10M | 7.44% | +$524.6K |
| Lantern Pharma Inc.(LTRN) | 864,435 | 249,397 | -615,038 | $1.18M | $1.04M | 2.50% | -$144.3K |
| In8bio Inc | 167,805 | 80,957 | -86,848 | $248.4K | $114.1K | 0.27% | -$134.2K |